Matches in Wikidata for { <http://www.wikidata.org/entity/Q98945589> ?p ?o ?g. }
- Q98945589 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q98945589 description "scientific article published on 19 August 2020" @default.
- Q98945589 description "wetenschappelijk artikel" @default.
- Q98945589 description "наукова стаття, опублікована 19 серпня 2020" @default.
- Q98945589 name "Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV" @default.
- Q98945589 name "Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV" @default.
- Q98945589 type Item @default.
- Q98945589 label "Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV" @default.
- Q98945589 label "Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV" @default.
- Q98945589 prefLabel "Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV" @default.
- Q98945589 prefLabel "Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV" @default.
- Q98945589 P1433 Q98945589-6979D4F6-5A15-4CE1-AF63-D6E2AD138831 @default.
- Q98945589 P1476 Q98945589-FF035BC8-A3B7-4C07-9381-79AE040F5540 @default.
- Q98945589 P2093 Q98945589-259D75B1-B167-4C02-8BAD-96E977F28902 @default.
- Q98945589 P2093 Q98945589-2D2EA156-905D-48F4-80C4-DD5FE5F18DD1 @default.
- Q98945589 P2093 Q98945589-46CE005C-9B2E-431C-A2DB-13D67751B6AF @default.
- Q98945589 P2093 Q98945589-53541137-356D-441D-A872-DEE5AF1E1FA8 @default.
- Q98945589 P2093 Q98945589-698ADAD6-63B2-4929-8DF3-0E132C28164D @default.
- Q98945589 P2093 Q98945589-6B563342-1423-4AB1-B089-9D008F20F45D @default.
- Q98945589 P2093 Q98945589-86E48582-7DC4-46F7-B5C6-398BA39D6062 @default.
- Q98945589 P2093 Q98945589-8CE4D218-C1CB-4BA5-93C8-5947F2D4EBFD @default.
- Q98945589 P2093 Q98945589-9B4030C8-3D6E-4265-B805-A5D42BB37E12 @default.
- Q98945589 P2093 Q98945589-DFD89C61-22B1-4728-8040-A767CAE03489 @default.
- Q98945589 P2093 Q98945589-EC40878C-3609-4684-B906-3400F197DC0C @default.
- Q98945589 P2093 Q98945589-F99B1C2D-41D8-42B1-B8D7-B77280267182 @default.
- Q98945589 P275 Q98945589-0B5B5ED1-65DC-4978-A0F7-09908496D2F0 @default.
- Q98945589 P2860 Q98945589-01BFBC6D-FF16-485F-A60E-BEEBC8962827 @default.
- Q98945589 P2860 Q98945589-052F7A8E-6912-49F0-A67D-28D8D277366C @default.
- Q98945589 P2860 Q98945589-05C71FC8-12AD-43FD-8796-7063ED0D3CB7 @default.
- Q98945589 P2860 Q98945589-108E4D46-4941-4698-92D0-0C3BF56D521D @default.
- Q98945589 P2860 Q98945589-25AA3766-194F-43F3-A70E-C85BA2A0713B @default.
- Q98945589 P2860 Q98945589-3A97C6E7-10E9-4AC4-A8A0-6EBDD3EAFF56 @default.
- Q98945589 P2860 Q98945589-48D9D47C-89E5-43EE-B9BF-BA96963F4F8A @default.
- Q98945589 P2860 Q98945589-4A551B79-CDE2-471B-A13B-8C0596DEFAEB @default.
- Q98945589 P2860 Q98945589-4E275144-7D60-4A72-9A18-63F70A020F90 @default.
- Q98945589 P2860 Q98945589-5AAB5485-1A85-4960-B1AB-67F3E5685188 @default.
- Q98945589 P2860 Q98945589-621DE945-8590-4ABE-9765-0F366F56ACEC @default.
- Q98945589 P2860 Q98945589-6464E73C-14DD-4F0B-BDA6-A4601C4590A2 @default.
- Q98945589 P2860 Q98945589-6C8F4B2A-57BA-4A9F-BECF-70FF63FE4713 @default.
- Q98945589 P2860 Q98945589-78362B11-5363-442B-B61E-0A1E617F9F50 @default.
- Q98945589 P2860 Q98945589-78727BAE-469B-4ED6-92EA-FE3BC5EB5625 @default.
- Q98945589 P2860 Q98945589-8AAB04F4-355B-4092-BE59-2C90B073A27D @default.
- Q98945589 P2860 Q98945589-B067615D-2DF9-4B12-9737-D0DBC93F2813 @default.
- Q98945589 P2860 Q98945589-B47F24A2-59F6-478D-B4A8-10FD499EFAAF @default.
- Q98945589 P2860 Q98945589-B6C3AC84-84FF-40F4-BE23-81BAB4F17A07 @default.
- Q98945589 P2860 Q98945589-BC3FDD0C-1647-474B-8AE8-92A81252B45E @default.
- Q98945589 P2860 Q98945589-BFF2BC00-0330-412D-9C82-D2255A1D0BE7 @default.
- Q98945589 P2860 Q98945589-C4D6A2ED-F2FB-4C57-82A8-7C6D31CDCEE2 @default.
- Q98945589 P2860 Q98945589-D18AB8FA-E92F-4B24-B3BB-A82CF81417A0 @default.
- Q98945589 P2860 Q98945589-D7E203FD-76DA-4D44-9CCC-68753D4A747D @default.
- Q98945589 P2860 Q98945589-DCBB7BB6-A9C0-4147-9E6B-9F52A9BD7D8B @default.
- Q98945589 P2860 Q98945589-ECB29407-FF2C-459C-BFC7-AFF0C61A9C43 @default.
- Q98945589 P2860 Q98945589-F1823622-996C-4E35-AAE4-B6832C0FDBA6 @default.
- Q98945589 P2860 Q98945589-F291E404-FD54-4210-9EBE-839656F9CA0B @default.
- Q98945589 P2860 Q98945589-F36E40B9-6024-4E9B-8DEA-FB3D2B40A383 @default.
- Q98945589 P2860 Q98945589-F82B589A-B44C-42A6-B926-D583ECDC6BE7 @default.
- Q98945589 P2860 Q98945589-FA01A0A0-9C9F-4725-94CB-132A6830D238 @default.
- Q98945589 P304 Q98945589-1AA5491E-5D11-4E95-8FBD-B32AED46DDB7 @default.
- Q98945589 P31 Q98945589-0455901C-BA28-4EFD-B86C-187335C45143 @default.
- Q98945589 P356 Q98945589-0F95C4F9-900D-4B80-9F71-7F436A687F78 @default.
- Q98945589 P478 Q98945589-D5598F04-899C-481F-B035-F6C8B3CE6B19 @default.
- Q98945589 P50 Q98945589-EF040C56-6AFF-4B7B-B125-5FE08ADB764C @default.
- Q98945589 P577 Q98945589-74388AC3-1AAA-4146-9671-B9125A800009 @default.
- Q98945589 P6216 Q98945589-D75AE16F-7024-40B9-B49E-B1521E614B9A @default.
- Q98945589 P698 Q98945589-6D529E85-821B-4359-9A0D-C47DD6889D6C @default.
- Q98945589 P921 Q98945589-FD09E52A-83CB-4134-B993-C60291E7C2A0 @default.
- Q98945589 P932 Q98945589-417740C7-CF70-43DD-B715-905BF203B596 @default.
- Q98945589 P356 1179554920951358 @default.
- Q98945589 P698 32884390 @default.
- Q98945589 P1433 Q5133775 @default.
- Q98945589 P1476 "Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV" @default.
- Q98945589 P2093 "Achim Rittmeyer" @default.
- Q98945589 P2093 "Amanda Tufman" @default.
- Q98945589 P2093 "Bernhard Ulm" @default.
- Q98945589 P2093 "Claas Wesseler" @default.
- Q98945589 P2093 "Eckart Laack" @default.
- Q98945589 P2093 "Fabian Reich" @default.
- Q98945589 P2093 "Gunther H Wiest" @default.
- Q98945589 P2093 "Jens Kollmeier" @default.
- Q98945589 P2093 "Joachim H Ficker" @default.
- Q98945589 P2093 "Martin Reck" @default.
- Q98945589 P2093 "Petra Hoffknecht" @default.
- Q98945589 P2093 "Petros Christopoulos" @default.
- Q98945589 P275 Q34179348 @default.
- Q98945589 P2860 Q27853359 @default.
- Q98945589 P2860 Q28131668 @default.
- Q98945589 P2860 Q29620051 @default.
- Q98945589 P2860 Q29620913 @default.
- Q98945589 P2860 Q34658812 @default.
- Q98945589 P2860 Q34662482 @default.
- Q98945589 P2860 Q36178042 @default.
- Q98945589 P2860 Q36378276 @default.
- Q98945589 P2860 Q38975751 @default.
- Q98945589 P2860 Q40163779 @default.
- Q98945589 P2860 Q40408396 @default.
- Q98945589 P2860 Q40550209 @default.
- Q98945589 P2860 Q47389008 @default.
- Q98945589 P2860 Q47567375 @default.
- Q98945589 P2860 Q47661423 @default.
- Q98945589 P2860 Q52586557 @default.